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Summary
Nowadays, the world hop industry is faced with one of the biggest crisis in the his-
tory. Permanent decrease of hopping rates in the world beer industry during last 20 
years caused many problems to hop producers all around the world. It resulted in the 
huge surpluses of hop stocks between years 2008 and 2010, the ages known as “years 
of famine” for hop farmers. Th e hop contains some compounds having medical, phar-
maceutical or biological activities, and xanthohumol is one of them. Xanthohumol 
is a biofl avonoid whose positive eff ect is confi rmed both in vitro and in vivo experi-
ments. It is successfully used in medical treatment of patients having diseases such 
as prostate and breasts cancer, osteoporosis, menopausal problems, and even HIV. 
However, such attributes of hop are strong argument to consider the restructuring 
of the world hop industry and forming a new supply chain, primarily oriented to the 
pharmaceutical industry.
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Introduction
Th e 23rd of April 1516 was surely the most important date in 
the history for every brewer and hop producer, because it was 
the date when Bavarian Duke Wilhelm IV declared the Purity 
Law (Barth et al., 1994; Moir, 2000). Th e sweet marriage between 
brewers and hop producers lasts for centuries. But from the be-
ginning of nineties of the 20th century the hop dosing rates per 
hL of beer wort is constantly decreasing because of global ten-
dency of beer producers to satisfy organoleptic preferences of 
younger generations. Suddenly, bitterness and hoppy aroma of 
beer became less desirable; fl avour less suitable for the young-
er population that was estimated as the most important target 
buyers/consumers by the marketing experts of the beer indus-
try. Consequently, the world hops areas are decreasing year aft er 
year with exceptions of some years, mostly because of temporary 
price fl uctuations (Barth and Meier, 2010). 
In order to satisfy more demandable requests of beer indus-
try, the research programs in hop genetics and breeding, hop 
physiology and processing into hop products, used to be intensi-
fi ed during the last twenty years. However, in spite of many im-
provements such as development of new hop cultivars, modern 
growing techniques, implementation of new plant protection 
measures, nowadays even some of the biggest and the most re-
spectable hop research organizations are faced with the simple 
survival and share the destiny of hop farmers. Both i.e. hop pro-
ducers and researchers are faced with the most important ques-
tion: - How to sustain? 
Th e aim of this paper is to give a critical overview of position 
of hops in the world beer industry. Th e intention is to point out 
the importance of hop secondary metabolites, in order to estab-
lish the new supply chain to the pharmaceutical industry. It could 
improve the economical sustainability of the world hop sector. 
Decrease of beer bitterness – problem for hop 
producers and beer technologists
It is already well known that invention of hop adding into 
wort was probably one of the most important innovations in 
history of brewing (Barth et al., 1994; Moir, 2000). Th e reason 
for that was primarily to decrease the sweetness of wort and to 
achieve a desirable beer bitterness aft er isomerisation of -acids 
(Bamforth, 2003; Briggs et al., 2004; Jaskula et al., 2007; Jaskula 
et al., 2008; Srečec et al., 2008a; Hanke, 2009; Hartmeier and 
Reiss, 2010; Jaskula et al., 2010) and, on the other hand, to pre-
vent the beer spoilage, caused mostly by lactic acid bacteria of 
Lactobacillus genera (Back, 1994; Kaltner et al., 2001; Sakamoto, 
2002; Sakamoto and Konings, 2003; Suzuki et al., 2004; Suzuki 
et al., 2006). According to Košir (1996), in the year of 1888 
Hayducka used the term -acids for hop substances forming a 
bitter resin of acid reaction with ions of lead. In 1925 Wöllmer 
developed the fi rst analytical method for their quantitative de-
tection (Howard and Tatchell, 1956; Forster, 1993) and -acids 
became name for the most important hop chemical compound 
in the world beer industry. 
Low hopping rates caused surpluses of hops and 
made hop production unstable 
rom the beginning of 1990 (Fig. 1) the hop dosing rates con-
stantly decreased (r = - 0.99; P < 0.0001) and consequently, the 
world hop acreage rose as well (r = - 0.85; P = 0.00001, Fig. 1) 
(Anon., 2010; Barth and Meier, 2010; Pavlovič, 2010). Moreover, 
in spite of constant growth of the world beer production, con-
sumption of -acids constantly decreases (r = - 0.73; P = 0.008, 
Fig. 2) due to decreasing of hop dosing rates (Fig. 2). Finally, in 
order to achieve some acceptable prices on the world hop market, 
which could guarantee their sustainability, the world hop produc-
ers decreased the hop acreage, but, because of implementation 
of new technologies and planting of hop cultivars with higher 
yields of -acids per hectare, the hop yields increased as well as 
production of -acids (r = 0.13; P  0.05, Fig. 3). 
Figure 1. Decreasing of hop dosing rates and world hop area 
since 1992 till 2009
Figure 2. Increasing of world beer production and decrease 
of α-acids consumption since 1992 till 2009
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During the years of 2008 and 2009, the world production 
of -acids increased (Fig. 3), but this was a short term change 
caused by the speculative prices on the world hop market in 
year of 2007. Currently, there is among 3 481 tones of -acids 
surplus on the world hop market. At the same time the hopping 
rate of 4.1 g of pure -acids per hL of wort is the lowest in his-
tory (Barth and Meier, 2010). 
Gushing – consequence of low hopping rates
Gushing is a phenomenon in which beer spontaneously, 
without agitation, vigorously overfoams out from the bottle 
(or some other packaging) immediately aft er opening. It has a 
negative infl uence on beer image and also causes big economic 
losses. Th e fungi developed on the kernels (caryopsis) of barley 
(Petr and Capouchová, 2001) are causing gushing and the most 
frequent among them are primarily of genera Fusarium, but 
also Aspergillus, Nigrospora, Penicillium and Stemphylium. 
Additionally, these fungi produce mycotoxins, like deoxyniva-
lenol (DON) that is connected with the development of gushing 
potential. So, screening of mycotoxins in barley and malt may 
off er a means of reducing beer gushing problems. Th e predictors 
of gushing activity are hydrophobins, small, moderately hydro-
phobic proteins produced also by fi lamentous fungi. Th ey have 
been found on the cell walls of hyphae and on spore surfaces 
and can also be secreted in the culture media (Sarlin et al., 2005; 
Stewart, 2006; Zapf et al., 2007). 
Humulones and linalool are hop constituents that prevent 
beer from gushing (Hanke et al., 2009), especially when hops 
are added at late stages of wort boiling. Linalool signifi cantly 
reduces the gushing volume and also decreases the gushing 
tendency of beer. 
Unfortunately, there is no available data about fi nancial losses 
caused by gushing. It would be very interesting to fi nd out the 
infl uence of so called “savings” in hops to compare the fi nancial 
consequences of returning the whole beer contingents from the 
market to the price of hops and hop products.
Xanthohumol “rediscovered” hop secondary 
metabolites
Th e fi rst literature sources about medical eff ects of hops 
was book “Physica”, the fi rst known pharmacopoeia, written by 
Abbess Hildegard von Bingen in 12th century (Schattenhofer, 
1989). Xanthohumol, a secondary metabolite, is a structurally 
simple prenylated chalcone that occurs only in the hop plant, 
where it is the principal prenylfl avonoid of the female hop cones 
(Stevens and Page, 2004). Dried hops contain up to 1.0% of xan-
thohumol, which is found in the lupulin glands together with 
- and β-acids and essential oils (De Keukeleire et al., 2003).. 
Flavonoids are known to have antiallergenic, antiinfl ammatory, 
antiviral, antifungal, antibacterial, antioxidative, antiprolifera-
tive, and anticancerogenic eff ects (Middleton and Kandaswami, 
1994). Practically all hop secondary metabolites exhibit more or 
less pronounced bioactive eff ects (Kondo, 2003). Nowadays, in 
the world scientifi c databases there are more than 250 references 
of published scientifi c papers considering the biosynthesis, accu-
mulation, medical eff ects and metabolism of xanthohumol. Th is 
compound is one of the most examined prenylated fl avonoids 
in the world. Unfortunately, the results of brewing tests showed 
that 80 to 90% of the added xanthohumol is eliminated during 
the brewing process. Th e eff ective dosages of xanthohumol or 
isoxanthohumol are minimally 0.35 mg per kg of body weight. 
It corresponds to approximately 30 mg per person per day or an 
average of 30 L of beer per day (Forster and Köberlein, 1998). 
Th erefore, it is not possible to attribute physiological eff ect to a 
small amount that is consumed by drinking beer. According to 
Stevens and Page (2004), one way to achieve higher level of xan-
thohumol is addition of the pure compound during the brewing 
process (Biendl et al., 2001) which requires extraction and puri-
fi cation of large amounts of this compound. However, depend-
ing on addition of roasted malt or special roasted malt extracts 
enriched with xanthohumol, dark beers with more than 10 mg 
of xanthohumol per liter were achieved as well as wheat beers 
with more than 1 mg of xanthohumol per liter (Wunderlich et al., 
2005; Magalhäes et al., 2008). Th ere are some commercial prod-
ucts of xanthohumol pills and beer enriched with xanthohumol 
on market (Biendl, 2007; Dhooghe et al., 2010). Consequently, the 
higher content of xanthohumol is also a goal in diff erent breed-
ing programs all over the world (Darby et al., 2003).
Biosynthesis and accumulation of hop secondary 
metabolites
Biosynthesis of hop secondary metabolites was not complete-
ly understood, until recently. It was known that biosynthesis of 
hop secondary metabolites starts in leaf cells (Čeh et al., 2007) 
and then they accumulated in hop glandular trichomes (Srečec 
et al., 2010b and 2011; Fig. 4). 
According to Nagel et al. (2008) and Wang et al. (2008), there 
are three independent biosynthetic pathways for terpene-derived 
natural products found in hop trichomes (Fig. 5). In order to un-
derstand the molecular basis for terpene accumulation in hop 
trichomes, Wang et al. (2008) constructed a trichome cDNA li-
brary and 9 816 cleansed expressed sequence tag (EST) sequences 
were obtained from random sequencing of 16 152 cDNA clones. 
Th e ESTs were assembled into 3 619 unigenes (1 101 contigs and 
2 518 singletons). Biosynthetic pathways for terpene-derived nat-
Figure 3. World production of α-acids since 1992 till 2009
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Figure 4. ESEM (environmental scan electron microscope 
photography) of hop peltate glandular trichomes in different 
stages of morphogenesis, developed from the epidermal cells of 
cone bract, Srečec et al., 2011 (magnification 113×, bar=200 μm)
ural products found in hop trichomes, showing EST abundance 
in the hop glandular trichome cDNA library. 
Th e same authors found that accumulation of monoterpene 
and sesquiterpene derived hop secondary metabolites in hop glan-
dular trichomes is more intensive during the third and fourth 
week aft er beginning of hop fl owering, which generally corre-
sponds with the results of Hirosawa et al. (1995) and Čeh et al. 
(2007). Accumulation of hop secondary metabolites is under the 
strong infl uence of external or climatic factors (Forster, 2001a, 
b; Srečec et al., 2004; Srečec et al., 2008b; Kučera and Kroft a, 
2009; Mozny et al., 2009). 
However, there is a large variability in accumulation of some 
most important hop secondary metabolites, such as α-acids and 
β-acids, xanthohumol, essential oils, total polyphenols and fl a-
vonoids. Such variability depends primarily on genotype of hop 
cultivars, external factors (the infl uence of crop year) and also 
on the level of processing the natural hop cones into hop prod-
ucts (Forster, 2001a,b; Kroft a et al., 2008; Čerenak et al., 2009; 
Srečec et al., 2009; Jelínek et al., 2010). Moreover, there is a vari-
ability in content of hop secondary metabolites even in wild hop 
Figure 5. Biosynthetic 
pathways for terpene-derived 
natural products found in 
hop trichomes, showing 
EST abundance in the hop 
glandular trichome cDNA 
library (Wang et al. 2008)
A, The pathway leading to 
dimethylallil pyrophosphate 
(DMAPP) biosynthesis. 
B, General reactions of 
mono- and sesquiterpene 
biosynthesis. C, 
Prenylflavonoid and bitter 












diphosphate synthase; HDR, 
1-hydroxy-2-methyl-2-
(E)-butenyl-4-diphosphate 
reductase; IPPI, isopentenyl 
diphosphate/dimethylallyl 
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populations, which is the consequence of their genetic diversity 
(Kroft a et al., 1998; Hampton et al., 2002, Patzak et al., 2010a,b; 
Srečec et al., 2010a). 
Medical eff ects of xanthohumol
It is well known that xanthohumol as much as other prenyl-
fl avonoids is cancer chemopreventive agent. Even low micromo-
lar concentrations cause inhibition of metabolic activation of 
procarcinogens, induction of carcinogen-detoxifying enzymes, 
and inhibition of tumour growth by inhibiting infl ammatory sig-
nals and angiogenesis (Stevens and Page, 2004). Xanthohumol 
is highly potent in suppressing the growth of human breast 
cancer cells (MCF-7) and ovarian cancer cells (Miranda et al., 
1999). Albini et al. (2006) refer that xanthohumol even in low 
concentrations of only 5 M, is very potent orally available an-
tiangiogenic chemoprevention agent whose mechanism targets 
endothelial cell migration, invasion, and proliferation. Lust et al. 
(2005) cultured in vitro lymphocytes from patients with B-cell 
chronic lymphocytic leukemia (B-CLL) in presence of xantho-
humol. Xantohumol induced killing of B-CLL cells at LD50 (24 
h) at 24.4 ± 6.6 M, independent of known adverse prognostic 
factors including functional loss of p53 (tumour protein 53). 
Colgate et al. (2007) found that xanthohumol at 2.5-50 M de-
creases cell viability, induces apoptosis and inhibits NF-kappaB 
(protein complex that controls transcription of DNA) activation 
in prostate epithelial cells. Buckwold et al. (2004) found that ul-
tra-pure preparations of xanthohumol ( 99 %) showed antiviral 
activity against bovine viral diarrhea virus (BVDV) and herpes 
simplex virus type 1 (HSV-1) and type 2 (HSV-2), and cytomeg-
alovirus (CMV). Wang et al. (2004) found that xanthohumol 
in half of maximal eff ective concentration (EC50) of 0.82, 1.28 
and 0.50 g mL-1, inhibits HIV-1 induced cytopathic eff ects, 
production of p24 (capsid protein of HIV) antigen and reverse 
transcriptase in C8166 lymphocytes. Xanthohumol also inhib-
ited HIV-1 replication in peripheral blood mononuclear cells 
(PBMC) with EC50 value of 20.74 g mL-1. However, the activ-
ity of recombinant HIV-1 reverse transcriptase and the HIV-1 
entry were not inhibited by xanthohumol. 
Xanthohumol has also estrogenic eff ects, because in vitro 
studies identifi ed 8-prenylnaringenin (8-PN) as one of the most 
potent estrogens in hops. 8-PN belongs to the group of prenylated 
fl avones, also containing isoxanthohumol, 6-prenylnaringenin, 
and a number of diprenylated analogues (Nikolić et al., 2006). 
Also, acne vulgaris is defi nitely one of the most common skin 
disease aff ecting children and adolescents caused by prolifera-
tion of bacteria such as Propionibacterium acnes, Staphylococcus 
epidermidis, Staphylococcus aureus, Kocuria rhizophila and 
Staphylococcus pyogenes. According to the results of Yamaguchi 
et al. (2009) hop extracts of xanthohumol and the lupulones 
(β-acids) showed strong inhibitory activities against all of the 
bacteria strains causing acne vulgaris. 
Nowadays, antioxidants are among popular over-the-counter 
and other nonprescription medications, because of the increas-
ing awareness on their importance for human health. Th ey are 
able to eliminate reactive oxygen and nitrogen radicals that ir-
reversibly damage live tissues and induce serious diseases, e.g. 
degenerative diseases, such as cardiovascular disease and cancer. 
Since oxidative damage is also considered to be the main cause 
of ageing it opens another fi eld of antioxidants application. Due 
to their antioxidant power, hop polyphenols may contribute 
positively to beer fl avour stability (Mudura et al., 2010) and use 
of hop as nutraceutical with antioxidative properties (Kroft a et 
al., 2008; Yamaguchi et al., 2009; Mudura et al., 2010) could be 
also expanded to gain an extra profi t.
Dosage and side eff ects of xanthohumol
Hussong et al. (2005) referred weak hepatotoxicity noticed in 
vivo only at doses of 100-1000 mg of xanthohumol per kilogram 
of Sprague Dawley rats body weight during the 28 days of diet. 
However, these concentrations are extremely high. For instance, 
average body weight in US population is approximately 86 kg 
for males and 74 kg for females (Ogden et al., 2004), and accord-
ing to these data, the daily input of 100 mg kg-1 of human body 
weight would be input of 8.6 kg of pure xanthohumol for males 
or 7.4 kg for females. Th e consumption of such high amounts of 
pure xanthohumol or beer containing such doses is not realistic.
Cancer disease statistics and hop surpluses 
According to the WHO statistics, in 2007 diff erent cancer 
diseases were cause of death for 7.6 million of people and some 
three quarters of them are in low- or middle-income countries 
(Anon., 2007). On the other hand, according to the statistics 
of American Cancer Society cancer caused 570 280 of deaths 
in 2005 and there were 1 372 910 estimated new cases (Anon., 
2005). In male population the most oft en is prostate cancer and 
in female breasts cancer (33% and 32%, respectively). Most of 
the world hop cultivars synthesize and accumulate in hop cones 
approximately less than 1% of xanthohumol. It means that, in 1 
tone of dried hop cones only 10 kg of xanthohumol is accumu-
lated, which is, according to Albini et al. (2006) suffi  cient daily 
chemopreventive dose for 5 643 341 of people. However, this is 
just minimal quantity for chemoprevention of malignant disease 
of critical groups in the population, without medical treatments 
of patients with some cancer disease. 
Particularly, hop preparations can be used in the most threat-
ened part of population, such as workers in chemical industry, the 
people who live in polluted areas, possible recurrences, i.e. cured 
patients who get over some cancer disease, etc. 
Conclusion
Th ere is a large quantity of research done on xanthohumol. Its 
biological activity is a strong argument to consider the restructur-
ing of the world hop industry and forming a new supply chain, 
primarily oriented towards pharmaceutical industry. It seems 
that using of nutraceuticals based on hop or functional food (e.g. 
beer enriched with xanthohumol) aimed primarily for chemo-
prevention and even for some medical treatments. Respecting 
the increasing number of some types of cancer such applica-
tion of hops constituents could mean a strong opportunity for 
future restructuring and sustainability of the world hop sector. 
In spite of a huge research work with encouraging results, 
which positive eff ects are confi rmed in vitro and in vivo only a 
few drugs or nutritional supplements containing xanthohumol 
are registered. It seems that the world pharmaceutical industry 
and medical science still do not pay attention to possible appli-
cations of hop compounds. 
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Unfortunately, at the moment huge quantities of hops are 
stored in hop warehouses and waiting to be sold or destroyed. 
Using of xanthohumol is opportunity to achieve sustainabil-
ity of world hop industry. At the same time it is possible to make 
new economic profi t from underutilized hop sources, because 
hop production is well established, experiential based and pro-
moted by new genetic research and technological improvements. 
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